CompletedNot Applicable

Lung Ultrasound in COVID-19 Patients

Netherlands137 participantsStarted 2020-06-01

Plain-language summary

To assess the prognostic performance of an early global LUS score with respect to the mortality in ICU and duration of ventilation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admitted to an ICU participating in this study between February 1, 2020 and April 30, 2020 * Confirmed with reverse transcriptase polymerase chain reaction (RT-PCR) COVID-19 infection * Having had received invasive ventilation * Having had examined at least once with lung ultrasound under invasive ventilation Exclusion Criteria: * Age \<18 years * First examination with LUS in patients already under extracorporeal membrane oxygenation (ECMO) support.

What they're measuring

Liberation from invasive ventilation

Timeframe: 28 days

Trial details

NCT IDNCT04487769

SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Covid19 trials